Increasing Mastectomy Rates—The Effect of Environmental Factors on the Choice for Mastectomy: A Comparative Analysis Between Canada and the United States

Annals of Surgical Oncology

Volumn 21, Issue 10, 2014, Pages 3173-3184

  Covelli, Andrea M ^a,b,c   Baxter, Nancy N ^a,b,c   Fitch, Margaret I ^a,d   Wright, Frances C ^a,b,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST NEOPLASMS; CANADA; CLINICAL PRACTICE; COMPARATIVE STUDY; DECISION MAKING; FEMALE; FOLLOW UP; HUMAN; INTERVIEW; MALE; MASTECTOMY; PATIENT REFERRAL; PHYSICIAN; PROGNOSIS; PSYCHOLOGY; SEGMENTAL MASTECTOMY; STATISTICS AND NUMERICAL DATA; UNITED STATES;

BREAST NEOPLASMS; CHOICE BEHAVIOR; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERVIEWS AS TOPIC; MALE; MASTECTOMY; MASTECTOMY, SEGMENTAL; ONTARIO; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS; PROGNOSIS; REFERRAL AND CONSULTATION; UNITED STATES;

EID: 84930978521     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-014-3955-4     Document Type: Article

References (55)

1. NIH consensus conference. Treatment of early-stage breast cancer. JAMA. 1991;265:391–5.
2. Lazovich D, Solomon CC, Thomas DB, Moe RE, White E. Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma. Cancer. 1999;86:628–37.
3. Gaudette LA, Goa RN, Spence A, Shi F, Joahnesen H, et al. Declining use of mastectomy for invasive breast cancer in Canada, 1981–2000. Can J Public Health. 2004;95:336–40.
4. Arrington AK, Jarosek SL, Virnig BA, et al. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer. Ann Surg Oncol. 2009;16:2697–704.
5. Jones NB, Wilson J, Kotur L, et al. Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution. Ann Surg Oncol. 2009;16:2691–6.
6. McGuire KP, Santillan AA, Kaur P, et al. Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients. Ann Surg Oncol. 2009;16:2682-90.
7. Tuttle TM, Habermann EB, Grund EH, et al. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol. 2007;25:5203-9.
8. Dragun AE, Huang B, Tucker TC, et al. Increasing mastectomy rates among all age groups for early stage breast cancer: a 10-year study of surgical choice. Breast J. 2012;18:318-25.
9. Dragun AE, Pan J, Riley EC, et al. Increasing use of elective mastectomy and contralateral prophylactic surgery among breast conservation candidates. Am J Clin Oncol. 2013;36(4):375-80.
10. Katipamula R, Degnim AC, Hoskin T, et al. Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol. 2009;27:4082-8.
11. Yao K, Stewart AK, Winchester DJ, et al. Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998–2007. Ann Surg Oncol. 2010;17:2554-62.
12. Gomez SL, Lichtensztajn D, Kurian AW, et al. Increasing mastectomy rates for early-stage breast cancer? Population-based trends from California. J Clin Oncol. 2010;26:e155-e157.
13. Mahmood U, Hanlon AL, Koshy M, et al. Increasing national mastectomy rates for the treatment of early stage breast cancer. Ann Surg Oncol. 2013;20:1436-43.
14. Breast cancer surgery in Canada, 2007–2008 to 2009–2010. In: Dabbs K, Porter G, Wai E (eds). Ottawa: Canadian Institute for Health Information; 2012.
15. King TA, Sakr R, Patil S, et al. Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. J Clin Oncol. 2011;29:2158-2164.
16. Brennan ME, Houssami N, Lord S, et al. Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: systematic review and meta-analysis of incremental cancer detection and impact on surgical management. J Clin Oncol. 2009;27:5640-9.
17. Benedict S, Cole DJ, Baron L, et al. Factors influencing choice between mastectomy and lumpectomy for women in the Carolinas. J Surg Oncol. 2001;76:6-12.
18. Nekhlyudov L, Bower M, Herrinton LJ, et al. Women’s decision-making roles regarding contralateral prophylactic mastectomy. J Natl Cancer Inst Monogr. 2005;(35):55-60.
19. Morrow M, Jagsi R, Alderman AK, et al. Surgeon recommendations and receipt of mastectomy for treatment of breast cancer. JAMA. 2009;302:1551-6.
20. Miller BT, Abbott AM, Tuttle TM. The influence of preoperative MRI on breast cancer treatment. Ann Surg Oncol. 2012;19:536-40.
21. Houssami N, Turner R, Morrow M. Preoperative magnetic resonance imaging in breast cancer: meta-analysis of surgical outcomes. Ann Surg. 2013;257:249-55.
22. Damle S, Teal CB, Lenert JJ, et al. Mastectomy and contralateral prophylactic mastectomy rates: an institutional review. Ann Surg Oncol. 2011;18:1356-63.
23. Stucky CC, Gray RJ, Wasif N, et al. Increase in contralateral prophylactic mastectomy: echoes of a bygone era? Surgical trends for unilateral breast cancer. Ann Surg Oncol. 2010;17 Suppl 3:330-7.
24. Hwang N, Schiller DE, Crystal P, et al. Magnetic resonance imaging in the planning of initial lumpectomy for invasive breast carcinoma: its effect on ipsilateral breast tumor recurrence after breast-conservation therapy. Ann Surg Oncol. 2009;16:3000-9.
25. Solin LJ, Orel SG, Hwang WT, et al. Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ. J Clin Oncol. 2008;26:386-91.
26. Katipamula R, Degnim AC, Hoskin T, et al. Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol. 2009;27:4082-8.
27. Katz SJ, Lantz PM, Janz NK, et al. Patient involvement in surgery treatment decisions for breast cancer. J Clin Oncol. 2005;23:5526-33.
28. Hawley ST, Lantz PM, Janz NK, et al. Factors associated with patient involvement in surgical treatment decision making for breast cancer. Patient Educ Couns. 2007;65:387-95.
29. Collins ED, Moore CP, Clay KF, et al. Can women with early-stage breast cancer make an informed decision for mastectomy? J Clin Oncol. 2009;27:519-25.
30. Arrington AK, Jarosek SL, Virnig BA, et al. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer. Ann Surg Oncol. 2009;16:2697-704.
31. Reitsamer R, Menzel C, Glueck S, et al. Predictors of mastectomy in a certified breast center-the surgeon is an independent risk factor. Breast J. 2008;14:324-29.
32. Katz SJ, Lantz PM, Zemencuk JK. Correlates of surgical treatment type for women with noninvasive and invasive breast cancer. J Womens Health Gend Based Med. 2001;10:659-70.
33. Coyne IT. Sampling in qualitative research. Purposeful and theoretical sampling: merging or clear boundaries? J Adv Nurs. 1997;26:623-30.
34. Barbour RS. Checklists for improving rigour in qualitative research: a case of the tail wagging the dog? BMJ. 2001;322:1115-7.
35. Charmaz K. Constructing grounded theory. Thousand Oaks: Sage; 2009.
36. McCann TV, Clarke E. Grounded theory in nursing research. Part 1: methodology. Nurse Res. 2002;11:7–16.
37. Lingard L, Albert M, Levinson W. Grounded theory, mixed methods, and action research. BMJ. 2008;337:a567.
38. Guest G. How many interviews are enough? An experiment with data saturation and variability. Field Methods. 2006;18:59–82.
39. Kuzel A. Sampling in qualitative inquiry. In: Crabtree B, Miller W (eds). Doing qualitative research. Newbury Park: Sage; 1992: pp 31–44.
40. Charmaz K: Grounded Theory in the 21st Century, in Denzin NK, Lincoln YS (eds): Handbook of qualitative research Thousand Oaks, CA, Sage 2000.
41. Bassett LW, Dhaliwal SG, Eradat J, et al. National trends and practices in breast MRI. AJR Am J Roentgenol. 2008;191:332-9.
42. Kreige M, Brekelmans CT, Boetes C, Besnard, PE, Zonderland HE, Obdeijn IM, et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med. 2004;351:427-37.
43. Sorbero MES, Dick AW, Burke Beckjord E, et al. Diagnostic breast magnetic resonance imaging and contralateral prophylactic mastectomy. Ann Surg Oncol. 2009;16:1597–1605.
44. Platt J. Geographic access to breast reconstruction and the influence of plastic surgeon availability. Toronto: Institute of Health Policy, Management and Evaluation, University of Toronto; 2013: pp 145.
45. Kruper L, Holt A, Xu XX, et al. Disparities in reconstruction rates after mastectomy: patterns of care and factors associated with the use of breast reconstruction in Southern California. Ann Surg Oncol. 2011;18:2158-65.
46. Christian CK, Niland J, Edge SB, et al. A multi-institutional analysis of the socioeconomic determinants of breast reconstruction: a study of the National Comprehensive Cancer Network. Ann Surg. 2006;243:241-9.
47. Chung A, Huynh K, Lawrence C, et al. Comparison of patient characteristics and outcomes of contralateral prophylactic mastectomy and unilateral total mastectomy in breast cancer patients. Ann Surg Oncol. 2012;19(8):2600-6.
48. Houn F, Helzlsouer KJ, Freidman NB, et al. The practice of prophylactic mastectomy: a survey of Maryland surgeons. Am J Public Health. 1995;85:801-5.
49. Veronesi U, Saccozzi R, Del Vecchio M, Banfi A, Clemente C, et al. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med. 1981;305:6–11.
50. Fisher B, Bauer M, Margolese R, et al. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med. 1985;312:665-73.
51. Nattinger AB, Hoffmann RG, Shapiro R, et al. The effect of legislative requirements on the use of breast-conserving surgery. N Engl J Med. 1996;335:1035-40.
52. Harris JR, Hellman S, Kinne DW. Limited surgery and radiotherapy for early breast cancer. CA Cancer J Clin. 1986;36:120-5.
53. Nayfield SG, Bongiovanni GC, Alciati MH, et al. Statutory requirements for disclosure of breast cancer treatment alternatives. J Natl Cancer Inst. 1994;86:1202-08.
54. State laws relating to breast cancer. In: US Department of Health And Human Services (ed). Division of Cancer Prevention and Control; 2008.
55. Scarth H, Cantin J, Levine M. Clinical practice guidelines for the care and treatment of breast cancer: mastectomy or lumpectomy? The choice of operation for clinical stages I and II breast cancer (summary of the 2002 update). CMAJ. 2002;167:154-5.